Preview

Rational Pharmacotherapy in Cardiology

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 14, No 2 (2018) EFFECTS OF SACUBITRIL/VALSARTAN ON THE ARTERIAL STIFFNESS AND LEFT VENTRICULAR-ARTERIAL COUPLING IN PATIENTS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION Abstract  similar documents
Zh. D. Kobalava, S. V. Villevalde, I. A. Meray, Е. E. Shkolnikova, O. I. Lukina
"... /ml/m2; p=0.005) and Ea/Ees ratio (from 2.26Ѓ}0.77 to 1.68Ѓ}0.32, p=0.05) was found after 12 months ..."
 
Vol 13, No 3 (2017) EFFECT OF SACUBITRIL/VALSARTAN ON NATRIURESIS, DIURESIS AND BLOOD PRESSURE IN HYPERTENSIVE PATIENTS Abstract  similar documents
Zh. D. Kobalava, S. V. Villevalde, I. A. Meray, O. I. Lukina
"... ; the maximum effect was achieved 2-4 hours after taking the medication (mean value 2.08, p=0.005). Sacubitril ..."
 
Vol 6, No 2 (2010) VALSARTAN IN EVERYDAY CLINICAL PRACTICE IN RUSSIA: ANTIHYPERTENSIVE EFFICACY AND INFLUENCE ON SEXUAL FUNCTION IN PATIENTS WITH ARTERIAL HYPERTENSION Abstract  similar documents
V. I. Podzolkov, V. A. Bulatov, A. V. Vigdorchik
"... 22 to 16% and from 44 to 30% respectively (р<0,05). Significant increase in the number of patients ..."
 
Vol 9, No 3 (2013) ANTIHYPERTENSIVE EFFICACY AND INFLUENCE ON SEXUAL FUNCTION OF VALSARTAN AND VALSARTAN AND HYDROCHLOROTHIAZIDE COMBINATION IN SMOKERS VERSUS NON-SMOKERS WITH ARTERIAL HYPERTENSION Abstract  similar documents
V. I. Podzolkov, A. V. Vigdorchik
"... decreased from 44.7 to 32.8% and from 29.1% to 23.2%, respectively (р<0.05). Significant increase ..."
 
Vol 8, No 1 (2012) THE COMPARATIVE STUDY OF EFFICACY AND TOLERABILITY OF GENERIC AND ORIGINAL VALSARTAN AS A MONOTHERAPY OR IN COMBINATION WITH HYDROCHLOROTHIAZIDE AND BISOPROLOL IN PATIENTS WITH ARTERIAL HYPERTENSION OF 1-2 DEGREE AND METABOLIC SYNDROME Abstract  similar documents
S. Yu. Martsevich, Yu. V. Lukina, N. A. Dmitrieva, O. V. Lerman, S. N. Tolpygina, V. P. Voronina, L. Yu. Drozdova
"... , respectively (p>0.05). Target BP was achieved in 23 patients (77%) in both randomized groups. Serious adverse ..."
 
Vol 14, No 2 (2018) PHARMACOECONOMIC ANALYSIS OF CHRONIC HEART FAILURE DRUG THERAPY IN PATIENTS WITH COMORBID CONDITIONS Abstract  similar documents
S. K. Zyryanov, A. E. Cheberda, D. Yu. Belousov
"... проблему. Клинические исследования показали высокую эффективность препарата сакубитрил/валсартан в терапии ..."
 
Vol 6, No 5 (2010) FIXED COMBINATION OF VALSARTAN AND AMLODIPINE: EFFECTS ON THE LEFT VENTRICULAR HYPERTROPHY REGRESSION, ALBUMINURIA REDUCTION AND ENDOTHELIUM FUNCTION IN HYPERTENSIVE PATIENTS WITH METABOLIC SYNDROME Abstract  similar documents
Ye. I. Tarlovskaya, N. S. Maksimchuk, I. Ye. Sapozhnikova, S. V. Malchikova
"... . Endothelium-dependent vasodilation increased in 3.6±7.2% (р=em0.05/em) in comparison with baseline, LVH decreased ..."
 
Vol 7, No 5 (2011) ECONOMIC BENEFITS OF LEFT VENTRICULAR HYPERTROPHY REGRESSION IN PATIENTS WITH ARTERIAL HYPERTENSION Abstract  similar documents
E. I. Tarlovskaya, N. S. Maksimchuk, S. V. Malchicova, M. V. Avksentieva, I. E. Sapozhnikova, Y. A. Balandina
"... decrease in LV mass from 205.8±50.4 to 181.9±45.1 g (pem0.05/em) was revealed. The model took into account ..."
 
Vol 15, No 1 (2019) Improving the cognitive functions in the middle-aged patients with essential arterial hypertension after the treatment with amlodipine/valsartan single-pill combination Abstract  similar documents
O. D. Ostroumova, E. V. Borisova, A. I. Kochetkov, T. M. Ostroumova, O. V. Bondarec
"... em0.05/em) and delayed recall (from 5.9±1.8 to 8.2±1.4 words; р0.001). Conclusion. In retrospective ..."
 
Vol 7, No 4 (2011) COMBINATION OF DIRECT RENNIN INHIBITOR - ALISKIREN, ANGIOTENSIN II RECEPTOR BLOCKER - VALSARTAN, AND CALCIUM CHANNEL BLOCKER - AMLODIPINE, IN THERAPY OF HYPERTENSIVE PATIENT WITH GOUT (CASE REPORT) Abstract  similar documents
O. V. Dralova, M. L. Maksimov
"... применения алискирена в комбинации с emвалсартаном/em и амлодипином у больного с emартериальной/em гипертонией и ..."
 
Vol 14, No 3 (2018) TRIPLE ANTIHYPERTENSIVE THERAPY: FOCUS ON EFFICACY AND PROGNOSIS Abstract  similar documents
O. D. Ostroumova, A. I. Kochetkov, A. V. Starodubova, I. V. Goloborodova, E. A. Smolyarchuk
"... антигипертензивной терапии и, в первую очередь, трехкомпонентных схем в лечении пациентов с emартериальной/em гипертонией ..."
 
Vol 9, No 3 (2013) ECONOMIC EVALUATION OF COMBINED THERAPY OF ARTERIAL HYPERTENSION BY MARKOV’S MODELING Abstract  similar documents
N. S. Maksimchuk-Kolobova, E. I. Tarlovskaya, S. V. Malchikova
"... . Significant decrease in LVM was observed in V/A group: from 225.1±71.7 to 186.3±44.5 g (pem0.05/em ..."
 
Vol 15, No 3 (2019) Effect of the Single-Pill Amlodipine/Valsartan Combination on Hypertrophy and Myocardial Deformation Characteristics in Middle-Aged Patients with Essential Arterial Hypertension Abstract  similar documents
A. I. Kochetkov, E. V. Borisova, O. D. Ostroumova, M. V. Lopukhina, G. V. Piksina
"... , there was a significantly (p=0.em005/em) increasing in this parameter at the end of the study (from -16.14±2.21% to -17.30±2 ..."
 
Vol 8, No 1 (2012) EFFICACY OF FIXED COMBINATION OF VALSARTAN, AMLODIPINE AND HYDROCHLOROTHIAZIDE IN COMPLEX THERAPY OF THE PATIENT OF VERY HIGH CARDIOVASCULAR RISK Abstract  similar documents
I. M. Sokolov, N. A. Zheleznyakova
"... Высокая распространённость emартериальной/em гипертонии в сочетании с высоким и очень высоким сердечно ..."
 
Vol 10, No 1 (2014) CHANGES IN THE PARAMETERS OF 24-HOUR BLOOD PRESSURE MONITORING AND ARTERIAL STIFFNESS IN PATIENTS WITH HYPERTENSION AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE TREATED WITH VALSARTAN Abstract  similar documents
N. A. Karoli, G. R. Dolishnya, A. P. Rebrov
"... Цель. Изучить изменения показателей суточного мониторирования emартериального/em давления (АД) и ..."
 
Vol 8, No 2 (2012) PRELIMINARY RESULTS OF COMPARATIVE PHARMACOECONOMIC PROSPECTIVE STUDY OF DIFFERENT THERAPIES OF ARTERIAL HYPERTENSION Abstract  similar documents
E. I. Tarlovskaya, N. S. Maksimchuk, S. V. Malchikova, M. V. Avksentieva
"... антигипертензивной терапии больных emартериальной/em гипертензией (АГ). Материал и методы. Обследовали 38 больных (11 ..."
 
Vol 14, No 6 (2018) The Impact of Valsartan/Amlodipine Single-Pill Combination on Blood Pressure and Vascular Stiffness in Patients with Grade 1-2 Essential Arterial Hypertension Abstract  PDF (Eng)  similar documents
E. V. Borisova, A. I. Kochetkov, O. D. Ostroumova
"... Цель. Изучить влияние фиксированной комбинации (ФК) emвалсартан/em/амлодипин (В/А) на уровень ..."
 
Vol 6, No 1 (2010) ANTIHYPERTENSIVE EFFICACY OF VALSARTAN IN SMOKERS VERSUS NON-SMOKERS WITH ARTERIAL HYPERTENSION: THE FIRST RESULTS OF RUSSIAN MULTICENTER OPEN STUDY Abstract  similar documents
V. I. Podzolkov, V. A. Bulatov, A. V. Vigdorchik
"... Цель. Изучить антигипертензивную эффективность, переносимость и приверженность лечению emвалсартаном/em ..."
 
Vol 8, No 5 (2012) EFFICACY OF COMBINED ANTIHYPERTENSIVE THERAPY IN ACHIEVEMENT OF TARGET BLOOD PRESSURE IN DIABETIC PATIENTS Abstract  similar documents
O. A. Koshel'skaya, O. A. Zhuravleva, R. S. Karpov
"... .0±8.3 to 125.0±7.6/76.8±4.9 mm Hg (pem0.05/em) and average daily BP (ABPM) decreased to 120.1±10.0/71.7±6 ..."
 
Vol 10, No 5 (2014) THE RATE AND CHARACTERS OF MASKED ARTERIAL HYPERTENSION AND MASKED INEFFECTIVENESS OF HYPERTENSION TREATMENT IN INDUSTRIAL WORKERS ACCORDING TO THE PREVENTIVE EXAMINATION Abstract  similar documents
M. I. Smirnova, E. M. Platonova, A. N. Britov, V. M. Gorbunov, A. D. Deev, Y. N. Koshelyaevskaya
"... , pem0.05/em), and higher body weight (85.4±13.3 vs. 81.3±10.1 kg, respectively; p=em0.05/em). Treated subjects ..."
 
Vol 2, No 1 (2006) EFFECT OF ANTIHYPERTENSIVE THERAPY WITH RILMENIDINE ON COGNITIVE FUNCTION IN ELDERLY HYPERTENSIVE PATIENTS Abstract  similar documents
S. V. Nedogoda, U. A. Brel, T. A. Tchalyaby, E. S. Kesareva, V. A. Tcoma
"... .01) and diastolic blood pressure (DBP) by 5.5% (pem0.05/em) was observed. Therapy with rilmenidine showed decrease ..."
 
Vol 13, No 6 (2017) BLOOD PRESSURE PHENOTYPES IN TREATED HYPERTENSIVE PATIENTS IN SUMMER AND WINTER: FOCUS ON MASKED UNCONTROLLED HYPERTENSION. Part 2. The main markers Abstract  PDF (Eng)  similar documents
M. I. Smirnova, V. M. Gorbunov, S. A. Boytsov, M. M. Loukianov, A. M. Kalinina, D. A. Volkov, A. D. Deev, Ya. N. Koshelyaevskaya, E. N. Belova
"... patients, the MUH phenotype in winter was characterized by a higher prevalence in men (56% vs 38%; pem0.05/em ..."
 
Vol 6, No 3 (2010) ANTIHYPERTENSIVE AND ANTIOXIDATIVE EFFECTS OF CARVEDILOL AND METOPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT/OBESITY Abstract  similar documents
V. A. Nevzorova, E. S. Potapova, O. V. Nastradin
"... from 7.03 [6.49;7.41] to 3.23 [2.88;3.57] μM/l (pem0.05/em) vs from 6.95 [6.51;7.39] to 6.08 [5.46;6.71] μM ..."
 
Vol 7, No 3 (2011) COMPARATIVE ANALYSIS OF ARTERIAL HYPERTENSION TREATMENT IN MEN AND WOMEN BASED ON THE RESULTS OF ACCORD STUDY (ACRIDILOLE IN COMBINATION THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION AND OBESITY OR TYPE 2 DIABETES) Abstract  similar documents
S. A. Shalnova, S. Yu. Martsevich, A. D. Deev, Yu. V. Lukina, E. N. Hoseva
"... regardless of gender , intergroup differences were significant (pem0,05/em). By the end of the study target BP ..."
 
Vol 7, No 1 (2011) INFLUENCE OF CHRONOTHERAPY WITH DIFFERENT ANTIHYPERTENSIVE DRUGS ON CIRCADIAN BLOOD PRESSURE PATTERN Abstract  similar documents
V. M. Gorbunov, E. Yu. Fedorova, A. D. Deev, O. Yu. Isaikina, V. G. Belolipetskaya, E. A. Zhabina
"... . Overall antihypertensive effect was more intense with morning ramipril (pem0.05/em) intake and evening ..."
 
Vol 4, No 4 (2008) EFFICACY AND SAFETY OF GINKGO BILOBA IN ELDERLY PATIENTS WITH CONTROLLED ARTERIAL HYPERTENSION AND CIRCULATORY ENCEPHALOPATHY Abstract  similar documents
V. V. Jakusevich, N. V. Semenova, I. A. Tihomirova, A. V. Muravyov, S. V. Lychenko
"... index (by 15,6%, рem0,05/em) and erythrocyte aggregation (degree of aggregation by 45,6%; average aggregate ..."
 
Vol 12, No 4 (2016) Morphometric changes of the left ventricle and characteristics of peripheral hemodynamics in patients with drug resistant hypertension Abstract  similar documents
R. R. Kushkhova, A. G. Avtandilov
"... .8 g/m vs 102.5±3.4 g/m² in Group 2 (pem0.05/em). The relative left ventricular wall thickness in Group 1 ..."
 
Vol 13, No 4 (2017) COMPARATIVE ANALYSIS OF THE EFFICACY OF FIXED-DOSE COMBINATIONS OF AMLODIPINE/LISINOPRIL AND BISOPROLOL/HYDROCHLORTHIAZIDE IN PATIENTS WITH ESSENTIAL ARTERIAL HYPERTENSION COMBINED WITH OBESITY AND OVERWEIGHT Abstract  similar documents
O. D. Ostroumova, A. I. Kochetkov, M. V. Lopukhina
"... ) variability at night (pem0.05/em) and a morning surge in SBP (p0.01), end systolic volume (pem0.05/em), systolic ..."
 
Vol 9, No 1 (2013) ASTHENIC DISORDERS IN ELDERLY PATIENTS WITH ARTERIAL HYPERTENSION: MANAGEMENT POTENTIAL OF MELDONIUM Abstract  similar documents
M. E. Statsenko, S. V. Nedogoda, S. V. Turkina, I. A. Tyshchenko, L. V. Poletaeva, V. V. Tsoma, A. A. Ledyaeva, E. V. Chumachok
"... a number of patients with general asthenia decreased on 70.5% (pem0.05/em), with physical asthenia — on 47 ..."
 
Vol 5, No 6 (2009) ORGANOPROTECTIVE EFFECTS OF THE FIXED COMBINATION OF ANGIOTENSIN-CONVERTING ENZYME INHIBITOR LISINOPRIL AND DIURETIC HYDROCHLOROTHIAZIDE Abstract  similar documents
E. A. Ryabikhin, M. E. Mozheiko
"... ,8±0,8 to 28,9±1,18 kg/m2 (pem0,05/em), respectively. In patients of the main group systolic and diastolic ..."
 
Vol 6, No 6 (2010) ACHIEVEMENT OF TARGET BLOOD PRESSURE LEVEL IN PATIENTS WITH ARTERIAL HYPERTENSION OF 2-3 DEGREE WITH FIXED COMBINATION OF ENALAPRIL OR LOSARTAN WITH HYDROCHLOROTHIAZIDE Abstract  similar documents
A. A. Kudryavtsev, A. S. Ryazanov, N. N. Eremenko, S. A. Kireev
"... of treatment (pem0.05/em). High frequency of target BP level achievement was observed in patients of groups 1 and 2 ..."
 
Vol 7, No 6 (2011) EFFECT OF METOPROLOL THERAPY ON THE ARTERIAL STIFFNESS Abstract  similar documents
V. E. Oleynikov, I. B. Matrosova, Y. A. Tomashevskaya, L. I. Gusakovskaya, E. A. Melnikova
"... .001] with the not significant changes of augmentation index (from 18.3±13.2 to 19.5±13.4; pem0.05/em). Significant reduction ..."
 
Vol 10, No 1 (2014) THE ROLE OF THE MATRIX METALLOPROTEINASES IN THE DEVELOPMENT OF LEFT VENTRICULAR HYPERTROPHY IN PATIENTS WITH ARTERIAL HYPERTENSION AND METABOLIC SYNDROME Abstract  similar documents
A. N. Zakirova, E. Z. Fatkullina, N. E. Zakirova
"... .61 and 183.6±17.2 ng/ml in grade 3 obesity vs 3.5±0.3 and 291.7±22.4 ng/ml in grade 1 obesity; pem0.05/em ..."
 
Vol 5, No 5 (2009) EFFICACY AND SAFETY OF VASOACTIVE BETA-BLOCKERS IN ACUTE PHARMACOLOGICAL TEST IN HYPERTENSIVE PATIENTS OF DIFFERENT AGES Abstract  similar documents
O. V. Fedorishina, A. A. Dzizinsky, K. V. Protasov, V. A. Protasova, T. I. Kucherova, E. G. Zakharova, D. D. Baskhaeva, T. S. Sukhoroslova, O. V. Perkova
"... of nebivolol did not have influence on systolic and pulse BP (-2.73 and +0.50 mm Hg, resp., pem0.05/em), unlike ..."
 
Vol 6, No 4 (2010) PHARMACOECONOMIC ANALYSIS OF CARVEDILOL THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION AND METABOLIC RISK FACTORS (ACCORDING TO THE CAMELLIA STUDY) Abstract  similar documents
S. Y. Martsevich, N. P. Kutishenko, A. D. Deev, S. A. Shalnova, R. G. Oganov
"... therapy of the patients treated with carvedilol was required less (pem0.05/em). Target BP levels were achieved ..."
 
Vol 8, No 3 (2012) COMPARATIVE EFFECTIVENESS PIPOFEZINE, TIANEPTINE AND CHLORPROTHIXENE IN PATIENTS WITH ATTENTION DEFICIT DISORDER , AND HYPERTENSION: AN OPEN NON-RANDOMIZED STUDY Abstract  similar documents
V. V. Glushchenko
"... of neurophysiological parameters (increase in EEG frequencies index) in groups 1 and 2 (from 0.37±em0.05/em to 0.54±0 ..."
 
Vol 9, No 2 (2013) PLEIOTROPIC EFFECTS OF PARATHYROIDECTOMY AND AGONIST CALCIUM-SENSITIVE RECEPTOR, CINACALCET Abstract  similar documents
L. V. Egshatyan, L. Ya. Rozhinskaya, N. S. Kuznetsov, M. Sh. Shamkhalova
"... and parathyroidectomy (pem0.05/em). BP reduction not requiring antihypertensive drugs dose adjustment was found in patients ..."
 
Vol 12, No 5 (2016) Arterial Hypertension in Patients with Rheumatoid Arthritis. What should be known and considered at diagnosis and treatment? Abstract  similar documents
N. M. Nikitina, T. A. Romanova, I. A. Afanas'ev, M. A. Tyapkina, A. P. Rebrov
"... was significantly higher than this in patients with essential hypertension (pem0.05/em). It is known that the basic anti ..."
 
Vol 13, No 4 (2017) USING A COMBINATION OF PERINDOPRIL, INDAPAMIDE AND ROSUVASTATIN IN THE TREATMENT OF PATIENTS WITH HYPERTENSION AND DYSLIPIDEMIA Abstract  similar documents
O. M. Drapkina, A. S. Lishuta
"... -density lipoprotein cholesterol (LDL-c) was found at the end of the study in all study groups (pem0.05/em ..."
 
Vol 1, No 2 (2005) ANTIHYPERTENSIVE, ORGAN PROTECTIVE, AND METABOLIC EFFICIENCY OF SPIRAPRIL IN PATIENTS WITH ARTERIAL HYPERTENSION Abstract  similar documents
M. V. Leonova, M. A. Demidova, A. V. Tarasov, Y. V. Belousov
"... % of patients, decreased levels of microalbuminuria (pem0,05/em) and β2-microglobulinuria (pem0,05/em), recovered ..."
 
Vol 15, No 5 (2019) Outpatient Register of Patients with Acute Myocardial Infarction: Assessment of the Hypertension Impact on Long-term Prognosis Abstract  similar documents
D. P. Sichinava, E. P. Kalaydzhyan, N. P. Kutishenko, S. Yu. Martsevich
"... women and 70 men; in women, AH was recorded more often than in men: 88.9% and 66.0%, respectively, pem0.05/em ..."
 
Vol 15, No 6 (2019) Seasonal Indicators of Blood Pressure, Data of Asthma Control Questionnaires and Quality of Life in Hypertensive Patients with Bronchial Asthma Abstract  similar documents
G. F. Andreeva, M. I. Smirnova, V. M. Gorbunov, A. S. Kurekhyan, Ya. N. Koshelyaevskaya
"... ones, and winter daytime systolic BP values (pem0.05/em) and clinical diastolic BP (p=0.004) – higher than ..."
 
Vol 13, No 4 (2017) CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND ARTERIAL HYPERTENSION: VASCULAR WALL AS THE TARGET ORGAN IN COMORBID PATIENTS Abstract  similar documents
N. A. Karoli, A. P. Rebrov
"... were associated with smoking status (r=0.61, p0.01), severity of bronchial obstruction (r=-0.49, pem0.05/em ..."
 
Vol 3, No 3 (2007) TREATMENT OF PATIENTS WITH ESSENTIAL HYPERTENSION 1-2 GRADE WITH METOPROLOL TARTRATE AND ANALYSIS OF HEART RATE VARIABILITY Abstract  similar documents
V. E. Oleinikov, V. A. Budanova, A. V. Kulyutsin
"... . They took combined therapy in 62% (p0,em005/em). 7 patients demonstrated normalization of disturbed diastolic ..."
 
Vol 2, No 2 (2006) CLINICAL EFFICACY AND PECULIARITY OF COMPLIANCE WITH 48-WEEK LONG THERAPY WITH EGILOK RETARD IN PATIENTS WITH MILD TO MODERATE HYPERTENSION Abstract  similar documents
V. E. Oleynikov, V. A. Budanova, A. V. Kulucin
"... Цель. У больных emартериальной/em гипертонией (АГ) изучить антигипертензивную эффективность метопролола ..."
 
Vol 8, No 3 (2012) EFFECT OF THE COMBINED ANTIHYPERTENSIVE THERAPY WITH TARGET BLOOD PRESSURE ACHIEVEMENT ON INTRARENAL BLOOD FLOW IN PATIENTS WITH TYPE 2 DIABETES Abstract  similar documents
O. A. Koshel'skaya, O. A. Zhuravleva
"... emартериального/em давления (АД) и скорости клубочковой фильтрации (СКФ) у больных emартериальной/em гипертонией (АГ) и ..."
 
Vol 7, No 5 (2011) AMLODIPINE IN CORRECTION OF HIGH RISK ARTERIAL HYPERTENSION: FOCUS ON MECHANISMS OF INFLAMMATION Abstract  similar documents
A. A. Tarasov, S. I. Davydov, T. A. Bezborodova, M. A. Gordeeva, A. R. Babaeva
"... by 17.1±5.8/11.4±4.0 mmHg (pem0.05/em) was revealed in the main group and by 13.6±4.7/8.9±5.3 mm Hg ..."
 
Vol 2, No 1 (2006) ANTIHYPERTENSIVE TREATMENT WITH COMBINED DRUG OF LOSARTAN AND HYDROCHLOROTHIAZIDE Abstract  similar documents
R. M. Linchak, K. M. Shumilova, A. D. Martinyuk, T. A. Gusaim, E. V. Semyonova, L. G. Zhirova, S. A. Boitsov
"... : in 24 hrs. (from 91.7±1.8 to 78.7±1.6 mmHg, pem0.05/em), in daytime (from 94.3±1.3 to 85.0±1.2 mmHg, pem0.05/em ..."
 
Vol 7, No 3 (2011) EFFICACY AND TOLERABILITY OF LERCANIDIPINE IN ELDERLY PATIENTS WITH MILD TO MODERATE HYPERTENSION IN A PLACEBO-CONTROLLED, DOUBLE-BLIND STUDY  similar documents
M. A. Ninci, R. Magliocca, A. Malliani
"... пожилых больных emартериальной/em гипертонией (АГ). Материал и методы. В многоцентровое рандомизированное ..."
 
Vol 9, No 5 (2013) CLINICAL IMPORTANCE OF ENDOTHELIAL DYSFUNCTION AND INSULIN RESISTANCE SYNDROME IN PATIENTS WITH GOUT ASSOCIATED WITH ARTERIAL HYPERTENSION Abstract  similar documents
N. N. Kushnarenko, A. V. Govorin
"... , pem0.05/em) and impairments of endothelium-dependent vasodilation (6.4% [3.3; 7.3%] vs 17.8% [12.7; 23 ..."
 
Vol 5, No 1 (2009) COMPARISON OF THERAPIES BASED ON CARVEDILOL AND METOPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT OR OBESITY. THE FIRST RESULTS OF CAMELLIA TRIAL Abstract  similar documents
S. Y. Martsevich, N. P. Kutishenko, E. V. Shilova, A. D. Deev, S. A. Shalnova, R. G. Oganov, I. A. Velishanina, E. G. Volkova, Yu. E. Voskanjan, L. I. Gapon, P. Ya. Dovgalevskij, V. Ya. Ermolina, E. M. Idrisova, N. N. Ilov, A. R. Kiseleva, S Yu. Levashov, V. A. Nevsorova, G. I. Nechaeva, T. N. Panova, I. I. Reznik, V. V. Skibickij, L. A. Sokolova, V. P. Terentev, N. V. Hailo, A. V. Shabalin, T. V. Shnyukova, V. V. Yakusevich, E. N. Akulina, V. A. Budanova, T. S. Bondarenko, V. P. Voronina, I. N. Gozhaja, I. I. Igricenco, A. V. Drogan, N. A. Dmitrieva, F. M. Dyshekova, A. I. Zaiceva, A. N. Ikovnikova, G. A. Ilicheva, I. S. Irhina, L. A. Kovaleva, O. N. Kutkina, E. A. Kudrjashev, A. Z. Leonidova, E. N. Loginova, M. P. Marganjan, O. V. Nastradin, A. N. Nikitina, I. N. Nikolskaja, I. E. Pashinceva, A. S. Petrochenko, O. M. Pasnenkova, E. S. Potapova, A. A. Serazhim, M. N. Sergeev, V. V. Sidorenko, V. A. Simonov, D. V. Sirotenko, I. N. Spanderashvili, A. N. Strunina, E. S. Timoschenko, S. N. Tolpygina, M. R. Redkina
"... and HCT was made more often in M group than in C group (pem0,05/em). Prescription of BB resulted ..."
 
Vol 15, No 4 (2019) Doctors’ Adherence to the Guidelines on the Diagnostics and Treatment of Arterial Hypertension Abstract  similar documents
N. B. Perepech, V. D. Shurygina, A. V. Tregubov
"... 2010 software package. Differences were regarded as significant at pem0.05/em. Results. The findings ..."
 
Vol 12, No 6 (2016) BURNOUT SYNDROME IN PATIENTS WITH WORKPLACE HYPERTENSION Abstract  similar documents
Yu. P. Zinchenko, E. I. Pervichko, O. D. Ostroumova
"... }3.67 points vs 24.6Ѓ}4.3 and 20.1Ѓ}5.7 points in group 2, and group of healthy, respectively; pem0.05/em ..."
 
Vol 14, No 5 (2018) Dynamics of Carotid Intima-Media Thickness, Parameters of Arterial Stiffness and Ambulatory Blood Pressure Monitoring during Therapy with Inhibitor of Tumor Necrosis Factor-Alpha in Patients with Early Psoriatic Arthritis Abstract  similar documents
E. I. Markelova, D. S. Novikova, T. V. Korotaeva, E. Yu. Loginova
"... .77) mm, p=0,01; as well as AS parameters: PWVcf from 9.9 (7.7; 17.7) to 9.2 (7.4; 10.6) m/s, pem0.05/em; RI ..."
 
Vol 14, No 6 (2018) The Situation with Valsartan – Commentary of S.A. Boytsov, Chief Cardiologist of Ministry of Health of Russia for the Central, Urals, Siberian and Far Eastern Federal Districts Abstract  PDF (Eng)  similar documents
artilce Editorial
 
Vol 13, No 3 (2017) TREATMENT OF ARTERIAL HYPERTENSION AND DYSLIPIDEMIA IN REAL CLINICAL PRACTICE. THE SYNERGY STUDY. Part 2 Abstract  similar documents
O. M. Drapkina, A. S. Luishuta
"... em0.05/em). This demonstrated an adequate antihypertensive and lipid-lowering effect of the applied ..."
 
Vol 5, No 6 (2009) RESULTS OF THE CAMELLIA TRAIL: IMPLEMENTATION IN A PRIMARY HEALTH CARE Abstract  similar documents
G. I. Nechaeva, E. N. Loginova
"... ,8±0,8 to 28,9±1,18 kg/m2 (pem0,05/em), respectively. In patients of the main group systolic and diastolic ..."
 
Vol 7, No 2 (2011) A COMPARATIVE STUDY OF THE EFFICACY AND TOLERABILITY OF ORIGINAL AND GENERIC BISOPROLOL IN MONOTHERAPY OR IN COMBINATION WITH S-AMLODIPINE AND INDAPAMIDE IN PATIENTS WITH ARTERIAL HYPERTENSION 1-2 DEGREES. RESULTS OF THE CLINICAL RANDOMIZED CROSSOVER STUDY Abstract  similar documents
S. Yu. Martsevich, S. N. Tolpygina, V. P. Voronina, O. V. Lerman, Yu. V. Lukina, N. A. Dmitrieva, I. V. Vashurina
"... .5±8.6 beats/min in group 2 (pem0.05/em for both groups). Significant dynamics of PQ interval were ..."
 
Vol 10, No 3 (2014) ENDOTHELIAL-TROPIC AND NEPHROPROTECTIVE EFFECTS OF COMBINED ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH TYPE 2 DIABETES MELLITUS Abstract  similar documents
M. E. Statsenko, M. V. Derevyanchenko, M. N. Titarenko, O. R. Pastuchova
"... of endothelin (ET-1) in serum and urine decreased by 26.1% and by 76.1%, respectively, pem0.05/em. A statistically ..."
 
Vol 11, No 1 (2015) METABOLIC EFFECTS OF COMBINED ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH TYPE 2 DIABETES Abstract  similar documents
M. E. Statsenko, M. V. Derevyanchenko
"... .4% (3.16±0.2 baseline vs 2.58±0.17 after 12 weeks of treatment, pem0.05/em). There was no deterioration ..."
 
Vol 14, No 5 (2018) The Potential of the Volumetric Sphygmography for the Diagnosis of Impaired Arterial Stiffness in Patients with Uncomplicated Arterial Hypertension and Its Possibilities for Evaluation of the Antihypertensive Therapy Effectiveness Abstract  similar documents
E. V. Borisova, A. I. Kochetkov, O. D. Ostroumova
"... emартериальной/em гипертонией (АГ) II стадии 1-2  степени и их динамики на фоне лечения  фиксированными комбинациями ..."
 
Vol 13, No 3 (2017) ARTERIAL STIFFNESS AND CARDIOVASCULAR RISK FACTORS IN YOUNG MEN (41-44 YEARS) Abstract  PDF (Eng)  similar documents
O. Yu. Isaykina, V. B. Rozanov, E. Yu. Zvolinskaya, H. S. Pugoeva, A. A. Alexandrov
"... /l; pem0.05/em), this indirectly reflected nutritional disorder and development of metabolic syndrome ..."
 
Vol 3, No 3 (2007) COMPARATIVE EVALUATION OF EFFICACY AND TOLERABILITY OF ORIGINAL AND GENERIC BISOPROLOL IN PATIENTS WITH ARTERIAL HYPERTENSION 1-2 GRADE Abstract  similar documents
S. N. Tolpygina, E. V. Shilova, S. Y. Martsevich
"... % of patients, respectively (pem0.05/em). After 6 weeks of treatment target SBP and DBP levels were achieved in 96 ..."
 
Vol 14, No 6 (2018) Effectiveness of Chrono-Pharmacotherapy Depending on the Salt Sensitivity of Patients with Arterial Hypertension and Diabetes Mellitus Type 2 Abstract  PDF (Eng)  similar documents
V. V. Skibitskiy, A. A. Kiselev, A. V. Fendrikova
"... diastolic BP by 22.1%; pem0.05/em), central aortic pressure (decrease in aortal systolic BP by 15.9%, aortal ..."
 
Vol 2, No 2 (2006) THE WAYS OF SYMPATHETIC SYSTEM OVERACTIVITY BLOCKING: RILMENIDINE VERSUS ATENOLOL Abstract  similar documents
Y. R. Kasherininov, E. K. Shavarova, A. A. Shavarov, N. V. Vachrameeva, A. N. Krutikov, E. V. Smirnova, A. O. Коnrady, E. V. Shlyakhto
"... ±66 mmol/min/l (pem0.05/em), and it increased from 937±86 to 989±88 mmol/min/l (pem0.05/em) in the atenolol ..."
 
Vol 12, No 1 (2016) State of a large vessels and microcirculation - a new target for antihypertensive therapy in patients with hypertension and type 2 diabetes Abstract  similar documents
M. E. Statsenko, M. V. Derevyanchenko
"... .1% (pem0.05/em for both), respectively. The treatment did not have a negative effect on glucose metabolism ..."
 
Vol 15, No 4 (2019) The Vascular Wall State and Microcirculation Parameters in Patients with Controlled and Uncontrolled Arterial Hypertension Abstract  similar documents
V. I. Podzolkov, A. E. Bragina, D. U. Natkina, T. A. Safronova, N. N. Nebieridze, E. V. Podshibyakina
"... .55 [27.08-34.4] and 22.82 [18.62-26.05], respectively (p em0.05/em). ADMA plasma concentration ..."
 
Vol 12, No 3 (2016) EFFECT OF OBSTRUCTIVE SLEEP APNEA SYNDROME ON ARTERIAL STIFFNESS IN PATIENTS AT HIGH CARDIOVASCULAR RISK Abstract  PDF (Eng)  similar documents
V. E. Oleynikov, N. V. Burko, L. I. Salyamova, K. A. Ziboreva
"... averaged was also higher in these patients (8.2±0.8 vs 9.1±1.1 m/sec; pem0.05/em). Mean level of flow-mediated ..."
 
Vol 8, No 4 (2012) COMPARISON OF THE INFLUENCE OF LONG-TERM TREATMENT BASED ON CARVEDILOL OR BISOPROLOL ON METABOLIC PARAMETERS IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT OR OBESITY RESULTS OF THE RANDOMIZED OPEN-LABEL PARALLEL-GROUPS STEPPED TRIAL CABRIOLET (PART I) Abstract  similar documents
S. Y. Martsevich, S. N. Tolpygina
"... demonstrated significant reduction in fasting plasma glucose level (-0.45±1.2 mM/l, p=0.01), uric acid (-em0.05/em±0 ..."
 
Vol 15, No 5 (2019) Association of rs556621 Polymorphism with Development of Stroke in Patients with Cardiovascular Pathology Abstract  similar documents
S. Yu. Nikulina, V. A. Shulman, A. A. Chernova, S. V. Prokopenko, D. A. Nikulin, I. M. Platunova, S. S. Tretyakova, V. N. Maksimov, A. A. Gurazheva
"... differences when comparing the frequencies of genotypes and alleles were also not detected (pem0.05/em ..."
 
Vol 12, No 5 (2016) Correction of Endothelial Dysfunction in Patients with Essential Hypertension when Using a Combination of Olmesartan/Lercanidipine and Zofenopril/Lercanidipine Abstract  similar documents
O. V. Zimnitskaya, M. M. Petrova
"... .10 [145.36; 329.33] vs 133.18 [73.07; 170.99] pg/ml, respectively; pem0.05/em). These patients had also ..."
 
Vol 6, No 1 (2010) ANGIOTENSIN II RECEPTOR ANTAGONISTS AND ACE INHIBITORS: OPTIMIZATION OF CHOICE FOR TREATMENT OF CARDIOVASCULAR DISEASES Abstract  similar documents
E. M. Khurs, A. V. Poddubnaya
"... ангиотензину II (АРА II) emвалсартана/em на этапах сердечно-сосудистого континуума (ССК). Материал и методы ..."
 
Vol 8, No 5 (2012) COMPARISON OF THE INFLUENCE OF LONG-TERM TREATMENT BASED ON CARVEDILOL OR BISOPROLOL ON METABOLIC PARAMETERS AND ERECTILE FUNCTION IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT OR OBESITY RESULTS OF THE RANDOMIZED OPEN-LABEL PARALLEL-GROUPS STEPPED TRIAL CABRIOLET (PART 2) Abstract  similar documents
S. Y. Martsevich, S. N. Tolpigina
"... .4±5.0 (p=0.002) for all items of EF questionnaire and +0.67±2.3 (рem0.05/em) for the 1-5,15 items of EF ..."
 
Vol 6, No 3 (2010) ASSOCIATION OF CLINICAL AND GENETIC FACTORS WITH LEFT VENTRICLE HYPERTROPHY IN ARTERIAL HYPERTENSION Abstract  PDF (Eng)  similar documents
T. Yu. Kuznetsova, D. V. Gavrilov, L. M. Samohodskaya, D. V. Rebrikov, S. A. Morozova, P. I. Makarevich, A. V. Kolotvin, A. B. Balatsky, A. Yu. Postnov, S. A. Boitsov
"... (OR 3,35, р0,0001), HT duration more than 5 years (OR 2,52, рem0,05/em), in obesity (OR 1,57, р=0,em005/em ..."
 
Vol 7, No 4 (2011) VASCULAR BED PECULIAR PROPERTIES IN PATIENTS WITH ISCHEMIC HEART DISEASE AND ARTERIAL HYPERTENSION. ROLE OF ANTIPLATELET THERAPY Abstract  similar documents
L. A. Haisheva, S. V. Shlyk
"... type vessels (13.27±0.53 vs 8.37±0.76 m/s). Strong positive correlation (r=0.71; pem0.05/em) between HT ..."
 
Vol 10, No 5 (2014) CHOICE OF THE INITIAL TREATMENT FOR MILD TO MODERATE ARTERIAL HYPERTENSION IN MOSCOW PRIMARY PRACTICE Abstract  similar documents
S. V. Gatsura, O. A. Gatsura, A. N. Golosova
"... declined from 44.4% in 2011-12 to 37.2% in 2013-14 (рem0.05/em). Angiotensin receptor blockers partially ..."
 
Vol 12, No 1 (2016) CONCOMITANT CARDIOVASCULAR DISEASES AND ANTIHYPERTENSIVE TREATMENT IN OUTPATIENT PRACTICE (BY THE RECVASA REGISTRY DATA) Abstract  PDF (Eng)  similar documents
M. M. Loukianov, S. A. Boytsov, S. S. Yakushin, S. Yu. Martsevich, A. N. Vorobyev, A. V. Zagrebelnyy, N. N. Nikulina, K. G. Pereverzeva, E. A. Pravkina, A. D. Deev, E. V. Kudryashov, E. N. Belova
"... (pem0.05/em). Conclusion. The RECVASA study data allowed revealing high incidence of concomitant CVDs ..."
 
Vol 13, No 3 (2017) GENETIC ASPECTS OF MODIFIABLE RISK FACTORS ASSOCIATED WITH ARTERIAL HYPERTENSION BY THE EXAMPLE OF THE INDIGENOUS POPULATION OF MOUNTAIN SHORIYA Abstract  similar documents
T. A. Mulerova, G. V. Artamonova, M. I. Voevoda, O. V. Gruzdeva, M. Yu. Ogarkov, O. L. Barbarash
"... in 5.11 (р=0.006), 5.41 (р=0.021), 2.73 (р=0.035) and 4.13 (р=0.em005/em) times, respectively ..."
 
Vol 9, No 4 (2013) EFFECTS OF TRIMETAZIDINE ON THE TRANSMITRAL BLOOD FLOW IN PATIENTS WITH DIASTOLIC HEART FAILURE Abstract  similar documents
Yu. N. Fedulaev, N. S. Pavlyuchenko, T. V. Pinchuk, S. Kh. Galachieva, A. A. Kozina, V. N. Ryzhenkov
"... of early left ventricle filling (27.6%, pem0.05/em) and the ratio of the two phases of left ventricle filling ..."
 
Vol 8, No 6 (2012) SARTANS AND ANGIOTENSIN CONVERTING ENZYME INHIBITORS: A DUEL BETWEEN TWO LEADERS OF PHARMACOTHERAPY OF CARDIOVASCULAR DISEASES Abstract  similar documents
K. A. Gyamdzhyan, M. L. Maksimov
 
Vol 14, No 2 (2018) HYPERTENSION AND DIABETES MELLITUS TYPE 2 Abstract  similar documents
M. E. Statsenko, M. V. Derevyanchenko
"... , as well as VAI (by 22.5%) and the percentage of patients with very high visceral fat (Δ%=-36.7, рem0.05/em ..."
 
Vol 8, No 6 (2012) MODERN VIEWS ON THE VARIABILITY OF BLOOD PRESSURE Abstract  similar documents
V. M. Gorbunov
"... Вариабельность emартериального/em давления (ВАД) в современном представлении охватывает несколько ..."
 
Vol 6, No 5 (2010) EFFECT OF BETA-BLOCKERS ON BLOOD PRESSURE, PERIOPERATIVE COMPLICATIONS AND HOSPITAL STAY DURATION IN PATIENTS WITH INTERMEDIATE RISK OF CARDIOVASCULAR COMPLICATIONS AFTER ROUTINE CHOLECYSTECTOMY: AN OPEN COMPARATIVE RANDOMIZED STUDY Abstract  similar documents
O. L. Barbarash, R. V. Repnikova, T. V. Shoforus, O. I. Golofaeva
"... blood pressure was lower during the carboxiperitoneum (pem0,05/em) and at the end of surgical procedure (pem0,05/em ..."
 
Vol 9, No 3 (2013) RENAL DENERVATION IN RESISTANT ARTERIAL HYPERTENSION Abstract  similar documents
V. A. Sulimov, A. V. Rodionov, A. A. Svetankova, I. E. Deneka
"... Рассматривается новый метод немедикаментозного лечения резистентной emартериальной/em гипертензии ..."
 
Vol 11, No 3 (2015) RENAL DENERVATION IN THE TREATMENT OF RESISTANT HYPERTENSION: RESULTS OF A ONE-YEAR OBSERVATIONAL STUDY Abstract  similar documents
V. A. Sulimov, A. V. Rodionov, A. A. Svetankova
"... Цель. Оценить влияние ренальной денервации (РДН) на emартериальное/em давление (АД), состояние миокарда ..."
 
Vol 10, No 1 (2014) ALCOHOL AND ARTERIAL HYPERTENSION Abstract  similar documents
O. D. Ostroumova, E. V. Saperova
"... напитка, характером потребления алкоголя и уровнем emартериального/em давления. Приведены данные о ..."
 
Vol 6, No 4 (2010) EFFECT OF ANTIHYPERTENSIVE THERAPY ON METABOLIC PROFILE AND ERECTILE FUNCTION IN HYPERTENSIVE MEN WITH HIGH CARDIOVASCULAR RISK: FOCUS ON THE COMBINATION OF LISINOPRIL AND AMLODIPINE Abstract  similar documents
M. N. Mamedov, M. V. Stroeva, M. N. Kovrigina, E. A. Poddubskaya
"... and diastolic BP decreased by 9.3 and 5.2%, and in 24 weeks – by 14.7 and 7.2% respectively (pem0.05/em). Target BP ..."
 
Vol 14, No 1 (2018) PROBLEMS OF EVALUATING BLOOD PRESSURE MEASUREMENT IN MODERN CLINICAL TRIALS (THE CASE OF SPRINT STUDY RESULTS) Abstract  similar documents
V. M. Gorbunov
"... исследовании SPRINT. Основной акцент сделан на использовавшиеся в нем методы измерения emартериального/em давления ..."
 
Vol 10, No 4 (2014) EXPERIENCE IN THE USE OF BISOPROLOL IN THE TREATMENT OF OUTPATIENT HYPERTENSIVE PATIENTS AFTER STROKE Abstract  similar documents
I. I. Esenova, L. N. Lisenker
"... Цель. Изучить динамику emартериального/em давления (АД), частоты сердечных сокращений (ЧСС), симпато ..."
 
Vol 4, No 3 (2008) ROLE OF BETA-ADRENOBLOCKERS IN ARTERIAL HYPERTENSION TREATMENT. WHAT DO EVIDENCE BASED MEDICINE DATA SHOW? Abstract  similar documents
S. Y. Martsevich
"... -адреноблокаторов в лече- нии emартериальной/em гипертонии. Анализируются данные последних рандомизированных клинических ..."
 
Vol 15, No 1 (2019) Hypertension and Dizziness: is there a Relation? Abstract  similar documents
V. A. Parfenov, T. M. Ostroumova, O. D. Ostroumova
"... Одной из самых частых жалоб больных emартериальной/em гипертензией (АГ) является жалоба на ..."
 
Vol 9, No 5 (2013) ARTERIAL HYPERTENSION IN SYSTEMIC VASCULITIS: CLINICAL FEATURES AND PRINCIPLES OF PATHOGENETIC THERAPY. PART I. CLINICAL, DIAGNOSTIC AND PATHOGENETIC ASPECTS Abstract  similar documents
E. A. Praskurnichy, N. G. Poteshkina
"... Статья посвящена  проблеме emартериальной/em гипертензии при системных васкулитах. Представлены данные ..."
 
Vol 9, No 6 (2013) ARTERIAL HYPERTENSION IN SYSTEMIC VASCULITIS: CLINICAL FEATURES AND PRINCIPLES OF PATHOGENETIC THERAPY. PART II. POSSIBILITIES OF OPTIMIZING OF ANTIHYPERTENSIVE TREATMENT Abstract  similar documents
E. A. Praskurnichy, N. G. Poteshkina
"... Статья посвящена проблеме emартериальной/em гипертензии при системных васкулитах. Представлены данные о ..."
 
Vol 13, No 2 (2017) PATIENTS WITH COMBINATION OF CHRONIC HEART FAILURE, HYPERTENSION AND HISTORY OF MYOCARDIAL INFARCTION: CLINICAL AND ANAMNESTIC CHARACTERISTICS, ADMINISTRATION OF ACE INHIBITORS, ANGIOTENSIN RECEPTOR BLOCKERS, -BLOCKERS AND ADHERENCE TO THE DRUG THERAPY (DATA OF OUTPATIENT REGISTRY RECVASA) Abstract  similar documents
M. M. Loukianov, A. N. Kozminsky, S. Yu. Martsevich, S. S. Yakushin, A. N. Vorobyev, A. V. Zagrebelnyy, R. P. Myasnikov, K. G. Pereverzeva, E. A. Pravkina, E. Yu. Andreenko, E. N. Belova, A. D. Deev, V. G. Klyashtorny, E. V. Kudryashov, S. A. Boytsov
"... angina class 3-4 (84.4% vs 66.4%, respectively). Patients with PICS significantly (pem0.05/em) more often ..."
 
Vol 13, No 5 (2017) BLOOD PRESSURE PHENOTYPES IN TREATED HYPERTENSIVE PATIENTS IN SUMMER AND WINTER: FOCUS ON MASKED UNCONTROLLED HYPERTENSION. PART 1: BLOOD PRESSURE PHENOTYPES PREVALENCE Abstract  PDF (Eng)  similar documents
M. I. Smirnova, V. M. Gorbunov, S. A. Boytsov, M. M. Loukianov, A. M. Kalinina, D. A. Volkov, A. D. Deev, Y. N. Koshelyaevskaya, E. N. Belova
"... Сезонная вариабельность показателей emартериального/em давления (АД) и сердечно-сосудистой ..."
 
Vol 15, No 6 (2019) Characteristics of Patients with Reproducible Masked Hypertension and its Diagnosis Approach Abstract  similar documents
М. I. Smirnova, V. M. Gorbunov, Ya. N. Koshelyaevskaya, A. D. Deev, D. A. Volkov, N. V. Furman, P. V. Dolotovskaya
"... Своевременная диагностика скрытой emартериальной/em гипертонии (АГ) является одной из актуальных задач ..."
 
Vol 6, No 1 (2010) EVOLUTION STAGES OF LOW RENIN HYPERTENSION Abstract  similar documents
S. V. Akhadov, G. R. Ruzbanova, G. S. Molchanovа
"... Цель. Выявить сходства и различия между эволюционными стадиями низкорениновой (НР) emартериальной/em ..."
 
Vol 14, No 2 (2018) SINGLE AND MULTIPLE ISCHEMIC BRAIN MICROLESIONS AFTER CAROTID ARTERY STENTING Abstract  similar documents
E. S. Bulgakova, T. V. Tvorogova, В. A. Rudenko, O. М. Drapkina
"... =-0.278; p0.01), systolic blood pressure (SBP) level before CAS (γ=0.190; pem0.05/em) and diastolic blood ..."
 
Vol 13, No 5 (2017) CHRONOTHERAPY OF HYPERTENSION: CURRENT STATE OF THE SCIENTIFIC PROBLEM Abstract  similar documents
V. M. Gorbunov, E. Y. Fedorova, E. V. Platonova
"... emартериальной/em гипертонии (АГ), позволяющий повысить эффективность лечения при нетрадиционном режиме назначения ..."
 
Vol 2, No 1 (2006) THE DAILY PROFILE OF BLOOD PRESSURE IN METABOLIC SYNDROME: COMPARABLE ANALYSIS OF THE EFFICACY OF MONOTHERAPY WITH ENALAPRIL AND UNCONTROLLED ANTIHYPERTENSIVE THERAPY Abstract  similar documents
M. N. Mamedov, V. M. Gorbunov, T. Sh. Dzahangirov
"... профиль emартериального/em давления (АД) у больных метаболическим синдромом (МС) по сравнению с ..."
 
1 - 100 of 636 Items 1 2 3 4 5 6 7 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)